机译:用PD-1抑制剂处理的晚期非小细胞肺癌中的结果和免疫相关不良事件的外周血标记物预测性
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Crit Care Med Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Nanchang Univ Dept Med Oncol Affiliated Hosp 1 17 Yongwai Zheng Rd Nanchang 330000 Jiangxi;
Lung cancer; Immunotherapy; Immune-related adverse events; Neutrophil-to-lymphocyte ratio; Lactate dehydrogenase; Prognostic nutrition index;
机译:晚期非小细胞肺癌患者的免疫相关不良事件和结果:疗效的预测标记?
机译:外周血标记识别用免疫检查点抑制剂治疗的晚期非小细胞肺癌中免疫相关毒性风险
机译:免疫相关不良事件对用Nivolumab治疗的晚期非小细胞肺癌患者存活的影响:来自多制度分析的长期结果
机译:复发相关死亡的蛋白质组学特征预测人非小细胞肺癌临床结果
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:与PD-1抑制剂治疗的先进非小细胞肺癌的患者相关的外周血血迹相关的外周血标记
机译:与PD-1抑制剂治疗的先进非小细胞肺癌的患者相关的外周血血迹相关的外周血标记
机译:评估生物标志物预测pD-1抑制剂mK-3475对非小细胞肺癌和脑转移患者的益处。